Purpose:
To assess refractive error, gender, and age-related differences in corneal topography of a normal population with Oculus Keratograph 4.
Methods:
This cross-sectional study included a total of 500 normal eyes of 500 individuals with ages ranging from 10 to 70 years. All participants underwent detailed ocular examinations, including visual acuity measurement, slit-lamp examination, and refractive error evaluation. Slit-lamp examination was performed for all individuals to rule out apparent corneal diseases. Corneal topography parameters were assessed using Oculus Keratograph. The data were analyzed based on gender, refractive error, and age groups using independent sample
t
-test and one-way analysis of variance.
Results:
Of a total of 500 participants (age: 29.51 ± 11.53 years) recruited for the present study, 66.4% were female, and 33.6% were male. The mean spherical equivalent of refraction was − 0.98 ± 1.65 diopters. Significant differences were noted in steep keratometry (
P
= 0.035) and corneal astigmatism (
P
= 0.014) between genders. Assessment of the data based on refractive error revealed significant differences in an index of vertical asymmetry (
P
< 0.001), index of height asymmetry (
P
= 0.003), and index of height decentration (
P
= 0.011). Considering age groups, significant differences were observed in flat keratometry readings (
P
< 0.001), mean corneal astigmatism (
P
= 0.02), minimum radius of curvature (
P
= 0.037), and apex power (
P
< 0.001).
Conclusions:
There was a prominent variation in some topographic parameters based on gender, age, and refractive error. The information on corneal parameters obtained with Oculus Keratograph from normal eyes provides a reference for comparison with diseased corneas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.